Radnor Capital Management, LLC Abb Vie Inc. Transaction History

Radnor Capital Management, LLC

$673 Million
Q3 2024

A detailed history of Radnor Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Radnor Capital Management, LLC holds 27,915 shares of ABBV stock, worth $4.94 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares

27,915

Previous 25,354 10.1%

Holding current value

$4.94 Million

Previous $4.35 Million 26.76%

% of portfolio

0.82%

Previous 1.33%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$163.84 - $199.33 $419,594 - $510,484	2,561 Added 10.1%	27,915 $5.51 Million
Q2 2024 Jul 12, 2024	BUY	$154.79 - $180.76 $40,245 - $46,997	260 Added 1.04%	25,354 $4.35 Million
Q1 2024 Apr 11, 2024	SELL	$159.82 - $182.1 $414,093 - $471,821	-2,591 Reduced 9.36%	25,094 $4.57 Million
Q4 2023 Jan 11, 2024	BUY	$137.6 - $154.97 $37,564 - $42,306	273 Added 1.0%	27,685 $4.29 Million
Q3 2023 Oct 12, 2023	BUY	$133.59 - $154.65 $269,451 - $311,929	2,017 Added 7.94%	27,412 $4.09 Million
Q2 2023 Jul 07, 2023	BUY	$132.51 - $164.9 $1.17 Million - $1.46 Million	8,829 Added 53.3%	25,395 $3.42 Million
Q1 2023 Apr 06, 2023	BUY	$144.61 - $166.54 $173,532 - $199,848	1,200 Added 7.81%	16,566 $2.64 Million
Q4 2022 Jan 09, 2023	SELL	$138.31 - $165.87 $97,785 - $117,270	-707 Reduced 4.4%	15,366 $2.53 Million
Q3 2022 Oct 12, 2022	SELL	$134.21 - $153.93 $5,368 - $6,157	-40 Reduced 0.25%	16,073 $2.16 Million
Q2 2022 Jul 11, 2022	BUY	$137.62 - $174.96 $64,543 - $82,056	469 Added 3.0%	16,113 $2.47 Million
Q1 2022 Apr 25, 2022	BUY	$131.98 - $163.75 $57,147 - $70,903	433 Added 2.85%	15,644 $2.54 Million
Q4 2021 Jan 20, 2022	BUY	$107.43 - $135.93 $355,271 - $449,520	3,307 Added 27.78%	15,211 $2.06 Million
Q3 2021 Oct 26, 2021	BUY	$106.4 - $120.78 $47,880 - $54,351	450 Added 3.93%	11,904 $1.28 Million
Q2 2021 Jul 21, 2021	BUY	$105.21 - $117.21 $15,781 - $17,581	150 Added 1.33%	11,454 $1.29 Million
Q1 2021 Apr 26, 2021	BUY	$102.3 - $112.62 $30,690 - $33,786	300 Added 2.73%	11,304 $1.22 Million
Q4 2020 Jan 13, 2021	BUY	$80.49 - $108.67 $43,062 - $58,138	535 Added 5.11%	11,004 $1.18 Million
Q3 2020 Nov 02, 2020	BUY	$85.91 - $100.83 $73,023 - $85,705	850 Added 8.84%	10,469 $917,000
Q2 2020 Jul 28, 2020	BUY	$73.37 - $98.18 $105,946 - $141,771	1,444 Added 17.66%	9,619 $954,000
Q2 2019 Jul 18, 2019	BUY	$65.7 - $83.98 $252,945 - $323,323	3,850 Added 89.02%	8,175 $594,000
Q1 2019 Apr 25, 2019	SELL	$77.14 - $90.79 $59,783 - $70,362	-775 Reduced 15.2%	4,325 $349,000
Q3 2018 Oct 04, 2018	BUY	$88.91 - $98.84 $44,455 - $49,420	500 Added 10.87%	5,100 $482,000
Q1 2018 Apr 20, 2018	SELL	$92.01 - $123.21 $35,975 - $48,175	-391 Reduced 7.83%	4,600 $435,000
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $8,956 - $9,821	-100 Reduced 1.96%	4,991 $483,000
Q2 2017 Aug 09, 2017	BUY	N/A	5,091	5,091 $369,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Radnor Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Radnor Capital Management, LLC with notifications on news.

Account

Radnor Capital Management, LLC Abb Vie Inc. Transaction History